Cerebral Edema, Hyponatremia Symptomatic, Osmotic Demyelination Syndrome
Conditions
Keywords
Treatment and outcome of severe hyponatremia
Brief summary
Electronic medical records dating back as far as available for each center to identify patients admitted to the hospital with a serum sodium ≤110 mmol/l. Data on patient demographics, presenting symptoms, vital signs, laboratory findings, treatment given, sodium correction rates, presence of risk factors for osmotic demyelination syndrome (ODS) and outcomes including suspected and MRI-confirmed ODS, in-hospital death, and imaging confirmation of cerebral edema
Interventions
Rapid Correction of hyponatremia
Sponsors
Study design
Eligibility
Inclusion criteria
* Serum sodium ≤110 mmol/L at admission to the hospital
Exclusion criteria
* Blood glucose \>15 mmol/L, spurious laboratory dataa
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Osmotic demyelination syndrome | 1 to 14 days | Neurological deterioration after treatment of hyponatremia |
| MRI-confirmed Osmotic Demyelination Syndrome | Within 30 days | Post treatment neurological deterioration with CPM and/or EPM |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cerebral edema | 2 days | Cerebral edema documented by imaging or death or respiratory arrest from suspected cerebral edema |
Countries
United States
Contacts
University of Rochester